Proteasome inhibitors: from research tools to drug candidates
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hershko, 1996, Lessons from the discovery of the ubiquitin system, Trends Biochem. Sci., 21, 445, 10.1016/S0968-0004(96)10054-2
Etlinger, 1977, A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes, Proc. Natl. Acad. Sci. USA, 74, 54, 10.1073/pnas.74.1.54
Matthews, 1989, Involvement of the proteasome in various degradative processes in mammalian cells, Proc. Natl. Acad. Sci. USA, 86, 2597, 10.1073/pnas.86.8.2597
Ciechanover, 1994, The ubiquitin-proteasome proteolytic pathway, Cell, 79, 13, 10.1016/0092-8674(94)90396-4
Rock, 1994, Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules, Cell, 78, 761, 10.1016/S0092-8674(94)90462-6
Craiu, 1997, Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation, J. Biol. Chem., 272, 13437, 10.1074/jbc.272.20.13437
Koepp, 1999, How the cyclin became a cyclin: regulated proteolysis in the cell cycle, Cell, 97, 431, 10.1016/S0092-8674(00)80753-9
Harris, 1999, Ubiquitin-mediated degradation of active Src tyrosine kinase, Proc. Natl. Acad. Sci. USA, 96, 13738, 10.1073/pnas.96.24.13738
Lu, 1998, Activation of protein kinase C triggers its ubiquitination and degradation, Mol. Cell. Biol., 18, 839, 10.1128/MCB.18.2.839
Pagano, 1995, Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27, Science, 269, 682, 10.1126/science.7624798
Meng, 1999, Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity, Proc. Natl. Acad. Sci. USA, 96, 10403, 10.1073/pnas.96.18.10403
Palombella, 1998, Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis, Proc. Natl. Acad. Sci. USA, 95, 15671, 10.1073/pnas.95.26.15671
Rock, 1999, Degradation of cell proteins and generation of MHC class I-presented peptides, Annu. Rev. Immunol., 17, 739, 10.1146/annurev.immunol.17.1.739
Mitch, 1996, Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway, New Engl. J. Med., 335, 1897, 10.1056/NEJM199612193352507
Hampton, 1996, Role of 26S proteasome and Hrd genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein, Mol. Biol. Cell, 7, 2029, 10.1091/mbc.7.12.2029
Murakami, 1992, Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination, Nature, 360, 597, 10.1038/360597a0
Turner, 2000, Peptides accelerate their uptake by activating a ubiquitin-dependent proteolytic pathway, Nature, 405, 579, 10.1038/35014629
Chain, 2000, Ubiquitin-mediated proteolysis in learning and memory, Mol. Neurobiol., 20, 125, 10.1007/BF02742438
Naidoo, 1999, A role for the proteasome in the light response of the timeless clock protein, Science, 285, 1737, 10.1126/science.285.5434.1737
Osterlund, 2000, Targeted destabilization of HY5 during light-regulated development of Arabidopsis, Nature, 405, 462, 10.1038/35013076
Schubert, 2000, Rapid degradation of a large fraction of newly synthesized proteins by proteasomes, Nature, 404, 770, 10.1038/35008096
Tarcsa, 2000, Ca2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26S proteasomes without ubiquitination, J. Biol. Chem., 275, 20295, 10.1074/jbc.M001555200
Jensen, 1995, Multiple proteolytic systems, including the proteasome, contribute to CFTR processing, Cell, 83, 129, 10.1016/0092-8674(95)90241-4
Ward, 1995, Degradation of CFTR by the ubiquitin-proteasome pathway, Cell, 83, 121, 10.1016/0092-8674(95)90240-6
Qu, 1996, Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity, J. Biol. Chem., 271, 22791, 10.1074/jbc.271.37.22791
Voges, 1999, The 26S proteasome: a molecular machine designed for controlled proteolysis, Annu. Rev. Biochem., 68, 1015, 10.1146/annurev.biochem.68.1.1015
Holzl, 2000, The regulatory complex of Drosophila melanogaster 26S proteasomes: Subunit composition and localization of a deubiquitylating enzyme, J. Cell Biol., 150, 119, 10.1083/jcb.150.1.119
Coux, 1996, Structure and functions of the 20S and 26S proteasomes, Annu. Rev. Biochem., 65, 801, 10.1146/annurev.bi.65.070196.004101
Yang, 1995, In vivo assembly of the proteasomal complexes, implications for antigen processing, J. Biol. Chem., 270, 27687, 10.1074/jbc.270.46.27687
Tanahashi, 2000, Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis, J. Biol. Chem., 275, 14336, 10.1074/jbc.275.19.14336
Rechsteiner, 2000, The proteasome activator 11 S REG (PA28) and class I antigen presentation, Biochem. J., 345, 1, 10.1042/0264-6021:3450001
Gronostajski, 1985, The ATP dependence of the degradation of short- and long-lived proteins in growing fibroblasts, J. Biol. Chem., 260, 3344, 10.1016/S0021-9258(19)83626-8
Baumeister, 1998, The proteasome: paradigm of a self-compartmentalizing protease, Cell, 92, 367, 10.1016/S0092-8674(00)80929-0
Groll, 1997, Structure of 20S proteasome from yeast at 2.4 Å resolution, Nature, 386, 463, 10.1038/386463a0
Löwe, 1995, Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution, Science, 268, 533, 10.1126/science.7725097
Groll, 2000, A gated channel into the proteasome core particle, Nature Struct. Biol., 7, 1062, 10.1038/80992
Wenzel, 1995, Conformational constraints in protein degradation by the 20S proteasome, Nature Struct. Biol., 2, 199, 10.1038/nsb0395-199
Glickman, 1998, A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3, Cell, 94, 615, 10.1016/S0092-8674(00)81603-7
Köhler, 2001, The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release, Mol. Cell, 7, 1143, 10.1016/S1097-2765(01)00274-X
P. Zwickl, A.L. Goldberg, W. Baumeister, Proteasomes in prokaryotes. In: D.H. Wolf, W. Hilt (Eds.), Proteasomes: The World of Regulatory Proteolysis, Landes Bioscience, Georgetown, TX, 1999, pp. 8–20.
Zwickl, 1999, An archaebacterial ATPase, homologous to ATPases in the eukaryotic 26 S proteasome, activates protein breakdown by 20 S proteasomes, J. Biol. Chem., 274, 26008, 10.1074/jbc.274.37.26008
Wilson, 2000, Biochemical and physical properties of the Methanococcus jannaschii 20S proteasome and PAN, a homolog of the ATPase (Rpt) subunits of the eucaryal 26S proteasome, J. Bacteriol., 182, 1680, 10.1128/JB.182.6.1680-1692.2000
Benaroudj, 2000, PAN, the proteasome activating nucleotidase from archaebacteria, is a molecular chaperone which unfolds protein substrate, Nature Cell Biol., 2, 833, 10.1038/35041081
Akopian, 1997, Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum, J. Biol. Chem., 272, 1791, 10.1074/jbc.272.3.1791
Kisselev, 1999, The sizes of peptides generated from protein by mammalian 26S and 20S proteasomes: implications for understanding the degradative mechanism and antigen presentation, J. Biol. Chem., 274, 3363, 10.1074/jbc.274.6.3363
Nussbaum, 1998, Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1, Proc. Natl. Acad. Sci. USA, 95, 12504, 10.1073/pnas.95.21.12504
Dick, 1998, Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants, J. Biol. Chem., 273, 25637, 10.1074/jbc.273.40.25637
Orlowski, 1990, The multicatalytic proteinase complex, a major extralysosomal proteolytic system, Biochemistry, 29, 10289, 10.1021/bi00497a001
Kisselev, 1999, Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown, Mol. Cell, 4, 395, 10.1016/S1097-2765(00)80341-X
Orlowski, 1993, Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids, Biochemistry, 32, 1563, 10.1021/bi00057a022
Cardozo, 1999, Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues, Biochemistry, 38, 9768, 10.1021/bi990735k
McCormack, 1998, Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continious assay and inhibition by tripeptide aldehydes and clasto-lactacystin β-lactone, Biochemistry, 37, 7792, 10.1021/bi980097q
Cardozo, 1996, Cleavage of Pro-X and Glu-X bonds catalyzed by the branched chain amino acid preferring activity of the bovine pituitary multicatalytic proteinase complex (20S proteasome), Arch. Biochem. Biophys., 334, 113, 10.1006/abbi.1996.0436
Schmidtke, 2000, Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20S proteasome, J. Biol. Chem., 275, 22056, 10.1074/jbc.M002513200
Myung, 2001, Lack of proteasome active site allostery as revealed by subunit-specific inhibitors, Mol. Cell, 7, 411, 10.1016/S1097-2765(01)00188-5
Rohrwild, 1996, HslV-HslU – a novel ATP-dependent protease complex in Escherichia coli related to the eukaryotic proteasome, Proc. Natl. Acad. Sci. USA, 93, 5808, 10.1073/pnas.93.12.5808
Brannigan, 1995, A protein catalytic framework with an N-terminal nucleophile is capable of self-activation, Nature, 378, 416, 10.1038/378416a0
Seemüller, 1995, Proteasome from Thermoplasma acidophilum – a threonine protease, Science, 268, 579, 10.1126/science.7725107
G. Salvesen, H. Nagase, Inhibition of proteolytic enzymes. In: R.J. Beynon, J.S. Bond (Eds.), Proteolytic Enzymes, IRL Press, Oxford, 1989, pp. 83–104.
Kisselev, 2000, Why does threonine, and not serine, function as the active site nucleophile in proteasomes?, J. Biol. Chem., 275, 14831, 10.1074/jbc.275.20.14831
Orlowski, 1997, Reactions of [14C]-3,4-dichloroisocoumarin with subunits of pituitary and spleen multicatalytic proteinase complexes (proteasomes), Biochemistry, 36, 13946, 10.1021/bi970666e
Fenteany, 1995, Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin, Science, 268, 726, 10.1126/science.7732382
Bogyo, 1997, Covalent modification of the active site Thr of proteasome beta-subunits and the E. coli homologue HslV by a new class of inhibitors, Proc. Natl. Acad. Sci. USA, 94, 6629, 10.1073/pnas.94.13.6629
Chen, 1996, Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly, Cell, 86, 961, 10.1016/S0092-8674(00)80171-3
Heinemeyer, 1997, The active sites of the eukaryotic 20S proteasome and their involvement in subunit precursor processing, J. Biol. Chem., 272, 25200, 10.1074/jbc.272.40.25200
Arendt, 1997, Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation, Proc. Natl. Acad. Sci. USA, 94, 7156, 10.1073/pnas.94.14.7156
Chapman, 1997, Emerging roles for cysteine proteases in human biology, Annu. Rev. Physiol., 59, 63, 10.1146/annurev.physiol.59.1.63
Vinitsky, 1992, Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex, Biochemistry, 31, 9421, 10.1021/bi00154a014
Lee, 1996, Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae, J. Biol. Chem., 271, 27280, 10.1074/jbc.271.44.27280
Wang, 1994, Calpain inhibition: an overview of its therapeutic potential, Trends Pharmacol. Sci., 15, 412, 10.1016/0165-6147(94)90090-6
Adams, 1998, Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids, Bioorg. Med. Chem. Lett., 8, 333, 10.1016/S0960-894X(98)00029-8
Harding, 1995, Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway, J. Immunol., 155, 1767, 10.4049/jimmunol.155.4.1767
Palombella, 1994, The ubiquitin-proteasome pathway is required for processing the NF-kappa-B1 precursor protein and the activation of NF-kappa-B, Cell, 78, 773, 10.1016/S0092-8674(94)90482-0
Tsubuki, 1996, Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine, J. Biochem., 119, 572, 10.1093/oxfordjournals.jbchem.a021280
Figueiredo-Pereira, 1994, A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell, J. Neurochem., 63, 1578, 10.1046/j.1471-4159.1994.63041578.x
Cotelle, 2000, 14-3-3s regulate global cleavage of their diverse binding partners in sugar-starved Arabidopsis cells, EMBO J., 19, 2869, 10.1093/emboj/19.12.2869
Adams, 1999, Proteasome inhibitors: a novel class of potent and effective antitumor agents, Cancer Res., 59, 2615
McCormack, 1997, Active site-directed inhibitors of Rhodococcus 20S proteasome. Kinetics and mechanism, J. Biol. Chem., 272, 26103, 10.1074/jbc.272.42.26103
Omura, 1991, Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells, J. Antibiot. (Tokyo), 44, 113, 10.7164/antibiotics.44.113
Corey, 1999, Total synthesis and biological activity of lactacystin, omuralide and analogs, Chem. Pharm. Bull. (Tokyo), 47, 1, 10.1248/cpb.47.1
Dick, 1996, Mechanistic studies on the inactivation of the proteasome by lactacystin – a central role for clasto-lactacystin β-lactone, J. Biol. Chem., 271, 7273, 10.1074/jbc.271.13.7273
Dick, 1997, Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells, J. Biol. Chem., 272, 182, 10.1074/jbc.272.1.182
Ostrowska, 1997, Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme, Biochem. Biophys. Res. Commun., 234, 729, 10.1006/bbrc.1997.6434
Geier, 1999, A giant protease with potential to substitute for some functions of the proteasome, Science, 283, 978, 10.1126/science.283.5404.978
Palmer, 1995, Vinyl sulfones as mechanism-based cysteine protease inhibitors, J. Med. Chem., 38, 3193, 10.1021/jm00017a002
Bogyo, 1998, Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes, Chem. Biol., 5, 307, 10.1016/S1074-5521(98)90169-7
Wang, 2000, Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity, Proc. Natl. Acad. Sci. USA, 97, 9990, 10.1073/pnas.180328897
Nazif, 2001, Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors, Proc. Natl. Acad. Sci. USA, 98, 2967, 10.1073/pnas.061028898
B.M. Kessler, D. Tortorella, M. Altun, A.F. Kisselev, E. Fiebiger, B.G. Hekking, H.L. Ploegh, H.S. Overkleeft, Extended-peptide based inhibitors efficiently target the proteasome and reveal overlapping specificities of catalytic subunits, Chem. Biol. 8 (2001) in press.
Meng, 1999, Eponemycin exerts its autitumor effect through the inhibition of proteasome function, Cancer Res., 59, 2798
Groll, 2000, Crystal structure of epoxomicin: 20S proteasome reveals a molecular basis for selectivity of alpha′,beta′-epoxyketone proteasome inhibitors, J. Am. Chem. Soc., 122, 1237, 10.1021/ja993588m
Lynas, 1998, Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals), Bioorg. Med. Chem. Lett., 8, 373, 10.1016/S0960-894X(98)00030-4
Chatterjee, 1999, P′-extended α-ketoamide inhibitors of proteasome, Bioorg. Med. Chem. Lett., 9, 2603, 10.1016/S0960-894X(99)00443-6
Lum, 1998, A new structural class of proteasome inhibitors that prevent NF-kappa B activation, Biochem. Pharmacol., 55, 1391, 10.1016/S0006-2952(97)00655-2
Loidl, 1999, Bivalency as a principle for proteasome inhibition, Proc. Natl. Acad. Sci. USA, 96, 5418, 10.1073/pnas.96.10.5418
Koguchi, 2000, TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093 – Taxonomy, production, isolation, and biological activities, J. Antibiot. (Tokyo), 53, 105, 10.7164/antibiotics.53.105
M. Groll, Y. Koguchi, R. Huber, J. Kohno, Crystal structure of the 20S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor, J. Mol. Biol. (2001) in press.
Kroll, 1999, The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome, Chem. Biol., 6, 689, 10.1016/S1074-5521(00)80016-2
Nam, 2001, Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo, J. Biol. Chem., 276, 13322, 10.1074/jbc.M004209200
Schmidtke, 1999, How an inhibitor of the HIV-I protease modulates proteasome activity, J. Biol. Chem., 274, 35734, 10.1074/jbc.274.50.35734
Rao, 1999, Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase, Proc. Natl. Acad. Sci. USA, 96, 7797, 10.1073/pnas.96.14.7797
Figueiredo-Pereira, 1996, The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20S proteasome, J. Biol. Chem., 271, 16455, 10.1074/jbc.271.28.16455
Meyer, 1997, Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-κB activation, FEBS Lett., 413, 354, 10.1016/S0014-5793(97)00930-7
Vinitsky, 1994, Inhibition of the proteolytic activity of the multicatalytic proteinase complex (proteasome) by substrate-related peptidyl aldehydes, J. Biol. Chem., 269, 29860, 10.1016/S0021-9258(18)43960-9
Bush, 1997, Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance, J. Biol. Chem., 272, 9086, 10.1074/jbc.272.14.9086
Lee, 1998, Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae, Mol. Cell. Biol., 18, 30, 10.1128/MCB.18.1.30
Zimmermann, 2000, Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1, Oncogene, 19, 2913, 10.1038/sj.onc.1203606
An, 2000, Protease inhibitor-induced apoptosis: accumulation of wt p53, p21(WAF1/CIP1) and induction of apoptosis are independent markers of proteasome inhibition, Leukemia, 14, 1276, 10.1038/sj.leu.2401812
Kumeda, 1999, Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells, Anticancer Res., 19, 3961
Drexler, 1997, Activation of the cell death program by inhibition of proteasome function, Proc. Natl. Acad. Sci. USA, 94, 855, 10.1073/pnas.94.3.855
Drexler, 2000, Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells, FASEB J., 14, 65, 10.1096/fasebj.14.1.65
Orlowski, 1998, Tumor growth inhibition induced in a murine model of human Burkitt’s lymphoma by a proteasome inhibitor, Cancer Res., 58, 4342
An, 1998, Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts, Cell Death Differ., 5, 1062, 10.1038/sj.cdd.4400436
Masdehors, 1999, Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin, Br. J. Haematol., 105, 752, 10.1046/j.1365-2141.1999.01388.x
Lopes, 1997, p53-dependent induction of apoptosis by proteasome inhibitors, J. Biol. Chem., 272, 12893, 10.1074/jbc.272.20.12893
Meriin, 1998, Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis, J. Biol. Chem., 273, 6373, 10.1074/jbc.273.11.6373
Rockwell, 2000, Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2), Arch. Biochem. Biophys., 374, 325, 10.1006/abbi.1999.1646
Machiels, 1997, Detailed analysis of cell cycle kinetics upon proteasome inhibition, Cytometry, 28, 243, 10.1002/(SICI)1097-0320(19970701)28:3<243::AID-CYTO9>3.0.CO;2-E
Dietrich, 1996, P53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts, Proc. Natl. Acad. Sci. USA, 93, 10815, 10.1073/pnas.93.20.10815
Wang, 1998, Role of proteasomes in T cell activation and proliferation, J. Immunol., 160, 788, 10.4049/jimmunol.160.2.788
Li, 2000, Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression, Proc. Natl. Acad. Sci. USA, 97, 3850, 10.1073/pnas.070047997
Van Antwerp, 1998, Inhibition of TNF-induced apoptosis by NF-kappa B, Trends Cell Biol., 8, 107, 10.1016/S0962-8924(97)01215-4
Princiotta, 2001, Cells adapted to the proteasome inhibitor 4-hydroxy-5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival, Proc. Natl. Acad. Sci. USA, 98, 513, 10.1073/pnas.98.2.513
Grimm, 1996, Proteasomes play an essential role in thymocyte apoptosis, EMBO J., 15, 3835, 10.1002/j.1460-2075.1996.tb00757.x
Sadoul, 1996, Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons, EMBO J., 15, 3845, 10.1002/j.1460-2075.1996.tb00758.x
Stefanelli, 1998, Inhibition of etoposide-induced apoptosis with peptide aldehyde inhibitors of proteasome, Biochem. J., 332, 661, 10.1042/bj3320661
Yang, 2000, Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli, Science, 288, 874, 10.1126/science.288.5467.874
Dimmeler, 1999, Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway, J. Exp. Med., 189, 1815, 10.1084/jem.189.11.1815
Oikawa, 1998, The proteasome is involved in angiogenesis, Biochem. Biophys. Res. Commun., 246, 243, 10.1006/bbrc.1998.8604
Teicher, 1999, The proteasome inhibitor PS-341 in cancer therapy, Clin. Cancer Res., 5, 2638
Hideshima, 2001, The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells, Cancer Res., 61, 3071
Glas, 1998, A proteolytic system that compensates for loss of proteasome function, Nature, 392, 618, 10.1038/33443
Gavioli, 2001, C-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells, Nature Cell Biol., 3, 283, 10.1038/35060076
Stoltze, 2000, Two new proteases in the MHC class I processing pathway, Nature Immunol., 1, 413, 10.1038/80852
Pahl, 1999, Activators and target genes of Rel/NF-kappaB transcription factors, Oncogene, 18, 6853, 10.1038/sj.onc.1203239
Grisham, 1999, Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome, Methods Enzymol., 300, 345, 10.1016/S0076-6879(99)00140-8
Soucy, 1999, A novel and efficient synthesis of a highly active analogue of clasto-lactacystin beta-lactone, J. Am. Chem. Soc., 121, 9967, 10.1021/ja991175f
Elliott, 1999, Proteasome inhibition: A novel mechanism to combat asthma, J. Allergy Clin. Immunol., 104, 294, 10.1016/S0091-6749(99)70369-6
Campbell, 1999, Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart, J. Mol. Cell. Cardiol., 31, 467, 10.1006/jmcc.1998.0880
Phillips, 2000, Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia, Stroke, 31, 1686, 10.1161/01.STR.31.7.1686
Vogt, 2000, Ubiquitin in retrovirus assembly: actor or bystander, Proc. Natl. Acad. Sci. USA, 97, 12945, 10.1073/pnas.97.24.12945
Schubert, 2000, Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2, Proc. Natl. Acad. Sci. USA, 97, 13057, 10.1073/pnas.97.24.13057
Schwarz, 2000, The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses, J. Immunol., 164, 6147, 10.4049/jimmunol.164.12.6147
Cascio, 2001, 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide, EMBO J., 20, 2357, 10.1093/emboj/20.10.2357
Elofsson, 1999, Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha′,beta′-epoxyketones, Chem. Biol., 6, 811, 10.1016/S1074-5521(99)80128-8
Loidl, 1999, Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes, Chem. Biol., 6, 197, 10.1016/S1074-5521(99)80036-2
Dantuma, 2000, Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells, Nature Biotechnol., 18, 538, 10.1038/75406
Stack, 2000, A ubiquitin-based tagging system for controlled modulation of protein stability, Nature Biotechnol., 18, 1298, 10.1038/82422